Mesa Laboratories


Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Mesa Laboratories
CIK #0000724004
SectorLife Sciences
IndustryIndustrial Instruments For Measurement, Display, And Control
Address12100 W 6th Ave
Lakewood, CO 80228
Source [EDGAR]
Market Cap, 13F ($MM)

We are headquartered in Lakewood, Colorado and our common stock is listed for trading on the Nasdaq Global Market ("Nasdaq") under the symbol MLAB.

As COVID-19 has continued to spread and significantly affect markets around the world, we implemented plans that are focused on ensuring the safety of our employees, while continuing to deliver our goods to customers across the world. Due to the critical nature of our products and services, we are generally exempt from governmental orders in the U.S. and other countries requiring businesses to suspend operations. Nevertheless, the pandemic brought a material disruption to the operations of the Company. To protect employees and comply with regulations and recommendations to limit gatherings and increase social distancing, we require office-based employees to work remotely, and we implemented enhanced safety protocols at our manufacturing facilities, including operating with split shifts to reduce the size of the workforce on premises, performing temperature checks at the start of shifts, and maximizing the amount of space between workspaces. We have taken aggressive steps to limit the exposure and enhance the safety of our facilities for employees working so that we can continue to supply products and services to hospitals and other customers, and we implemented strict travel restrictions. Additionally, we are working closely with our suppliers to develop contingency plans for potential supply interruptions.

We believe that we have the liquidity required to continue operations during this volatile period. As of March 31, 2020, we had a cash balance of $81.4 million, and the principle on our convertible debt is not due until 2025. However, we are taking steps to reduce cash outlays and expenses, including limiting travel, freezing wage increases, and reducing the hiring of new employees. Additionally, we believe that we have access to equity and credit markets if necessary. However, additional equity or debt financing, or other transactions, may not be available on acceptable terms, if at all. Given the uncertainty regarding the spread of the virus and the timing of economic recovery, the related financial impact cannot be reasonably predicted or estimated at this time.

CIK Filing 2011 - 2021
[0000724004] 10-K
[0000724004] 10-Q
[0000724004] 3
[0000724004] 4
[0000724004] 5
[0000724004] 8-K
[0000724004] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Mesa Laboratories Inc /CO [2020-02-11] 6.78
Price T Rowe Associates Inc /MD/ Mesa Laboratories Inc /CO [2019-02-14] 7.4
BlackRock Inc Mesa Laboratories Inc /CO [2019-02-08] 6.6
Nine Ten Partners LP Mesa Laboratories Inc /CO [2015-02-17] 5.9
Conestoga Capital Advisors LLC Mesa Laboratories Inc /CO [2015-01-14] 11.16
Form 3/4/5 Filer 2011-2021
Kelly David M
Sullivan John James
Sakys John V
Hall Shannon
Guillemin Evan
Schmieder John Bradley
Alltoft Jennifer Sadie
Archbold Brian David
Owens Gary M
Dinoia Gregory
Perez David Brian
Dwyer Robert V
Brooks Michael T
Campbell H Stuart
SEG Ventures LLC
Adriance Glenn E
Schmieder Luke R
Peterson Steven W
Tranmer Michael
Shares Owned of 3,852,844.9 Total
Firm Period DFND Voting Shares
BlackRock Inc. [2020-09-30] SOLE 743,818.0 749,976.0
Conestoga Capital Advisors LLC [2020-09-30] SOLE 498,997.0 499,349.0
Royce & Associates LP [2020-09-30] SOLE 310,454.0 310,454.0
Price T Rowe Associates Inc /MD/ [2020-09-30] SOLE 85,131.0 308,078.0
Vanguard Group Inc [2020-09-30] SOLE 0.0 287,539.0
Invesco Ltd. [2020-09-30] DFND 0.0 275,790.0
Ranger Investment Management LP [2020-09-30] SOLE 173,065.0 173,065.0
State Street Corp [2020-09-30] DFND 151,485.0 172,397.0
Atlanta Capital Management Co L L C [2020-09-30] SOLE 123,542.0 135,334.0
Artisan Partners Limited Partnership [2020-09-30] SOLE 106,201.0 127,906.0
Schroder Investment Management Group [2020-09-30] SOLE 95,976.0 95,976.0
Kayne Anderson Rudnick Investment Management LLC [2020-09-30] DFND 0.0 90,788.0
Kayne Anderson Rudnick Investment Management LLC [2020-09-30] SOLE 70,351.0 77,655.0
Goldman Sachs Group Inc [2020-09-30] DFND 73,278.0 76,806.0
Northern Trust Corp [2020-09-30] DFND 23,879.0 76,455.0
Geode Capital Management LLC [2020-09-30] DFND 67,088.0 67,088.0
Wells Fargo & Co/Mn [2020-09-30] DFND 34,164.0 62,436.0
Eagle Asset Management Inc [2020-09-30] SOLE 57,015.0 57,015.0
Ameriprise Financial Inc [2020-09-30] DFND 0.0 54,794.0
Bank of New York Mellon Corp [2020-09-30] DFND 47,094.0 48,883.0
Moody Aldrich Partners LLC [2020-09-30] SOLE 14,795.0 46,016.0
DF Dent & Co Inc [2020-09-30] SOLE 45,613.0 45,613.0
Russell Investments Group, Ltd. [2020-09-30] DFND 40,145.0 42,920.0
Renaissance Technologies LLC [2020-09-30] SOLE 35,689.0 42,100.0
Comerica Bank [2020-09-30] SOLE 4,724.0 37,395.0
Principal Financial Group Inc [2020-09-30] DFND 34,675.0 34,675.0
Charles Schwab Investment Management Inc [2020-09-30] SOLE 31,289.0 31,289.0
Putnam Investments LLC [2020-09-30] DFND 17.0 26,467.0
New York State Common Retirement Fund [2020-09-30] SOLE 25,905.0 25,905.0
Thrivent Financial for Lutherans [2020-09-30] SOLE 21,836.0 21,836.0
Prev | Page 1 | Next
Terms | Privacy | Guide